FentaNYL Citrate in 0.9% Sodium Chloride 1 mg per 100 mL
Lack of Assurance of Sterility
Every FDA drug recall initiated in 2022, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,390 recalls, newest first.
Lack of Assurance of Sterility
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
Failed Dissolution Specifications: below specification limits for dissolution.
Failed Dissolution Specifications: below specification limits for dissolution.
Labeling: Label Error on Declared Strength
Labeling: Product Contains Undeclared API - product contains undeclared ethyl alcohol
Labeling: Product Contains Undeclared API - product contains undeclared ethyl alcohol
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Failed Dissolution Specifications
Failed dissolution specifications.
CGMP Deviations;
CGMP Deviations
CGMP Deviations
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.